Loading insider details...
Beta
Latest Form 4 (Aug 5, 2026): Disposition to Issuer of 975 GRTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | Galera Therapeutics, Inc. (GRTX) | Disposition to Issuer | 975 | n/a |
| Nov 24, 2025 | Galera Therapeutics, Inc. (GRTX) | Sale | 70,000 | $1.4K |
| May 5, 2025 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 6,000,000 | n/a |
| Aug 20, 2024 | Galera Therapeutics, Inc. (GRTX) | Sale | 67,015 | $4.8K |
| Mar 14, 2023 | Galera Therapeutics, Inc. (GRTX) | Purchase | 100,000 | $168.1K |
| Mar 1, 2023 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 440,000 | n/a |
| Mar 2, 2022 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 264,400 | n/a |
| Mar 30, 2021 | Galera Therapeutics, Inc. (GRTX) | Exercise/Conversion | 170,075 | $182.0K |
| Jan 28, 2021 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 190,000 | n/a |
| Feb 4, 2020 | Galera Therapeutics, Inc. (GRTX) | Grant/Award | 186,087 | n/a |